Analyst Ratings for PRA Health Sciences Inc. (PRAH)Updated: 2017-07-26
An average rating of Buy has been given to PRA Health Sciences Inc. (NASDAQ:PRAH) by analysts covering the stock. Last month, PRAH received an average rating of Buy.
8 analysts declared PRAH a buy, 1 gave an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
Many analysts weighed in on price targets for PRAH. The highest price target was 90, implying a possible profit of 17.17 percent. The lowest price target was 69, implying potential capital losses of -10.17 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. That number becomes -0.68 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed upwards by 0.16 percent. If we look at the last 90 days instead, we find a net average change of 0.32 percent in FY estimates.
People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.
The growth rate of PRAH's earnings is estimated by analysts to be 79.29 percent. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of PRAH is 0.57.
In the trailing 52-weeks, PRAH hit 79.98 at the highest peak, while it's lowest trading point was 43.08. The current market price is above the trailing year's low by 78.3 percent, and 3.96 percent below the high. PRAH has a price/earnings ratio of 45.18. Investors typically compare the P/E ratio to a company's peers in the industry. The PRAH value stock report compares PRAH to some of its peers using value stock charts. The stock has a market capitalization of $4.8 billion. PRAH will post this quarters earnings in days, on 0000-00-00.